A detailed history of Aspire Private Capital, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Aspire Private Capital, LLC holds 84 shares of DXCM stock, worth $6,740. This represents 0.0% of its overall portfolio holdings.

Number of Shares
84
Previous 84 -0.0%
Holding current value
$6,740
Previous $9,000 44.44%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022

BUY
$67.99 - $132.89 $4,283 - $8,372
63 Added 300.0%
84 $6,000
Q3 2021

Nov 15, 2021

BUY
$106.71 - $143.18 $2,240 - $3,006
21 New
21 $11,000
Q1 2021

May 26, 2021

SELL
$84.79 - $104.74 $1,780 - $2,199
-21 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$95.51 - $112.95 $2,005 - $2,371
21 New
21 $9,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Aspire Private Capital, LLC Portfolio

Follow Aspire Private Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspire Private Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspire Private Capital, LLC with notifications on news.